BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 24388162)

  • 1. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure.
    Juillière Y; Suty-Selton C; Riant E; Darracq JP; Dellinger A; Labarre JP; Druelle J; Mulak G; Danchin N; Jourdain P;
    Arch Cardiovasc Dis; 2014 Jan; 107(1):21-32. PubMed ID: 24388162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
    Arch Cardiovasc Dis; 2014 Feb; 107(2):112-21. PubMed ID: 24388161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study on characteristics of congestive heart failure patients with preserved versus abnormal left ventricular systolic function and evaluation effects of therapy].
    Zhan H; Tse HF; Cao JM; Lau CP
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):210-5. PubMed ID: 16647010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
    Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.
    Tarantini L; Faggiano P; Senni M; Lucci D; Bertoli D; Porcu M; Opasich C; Tavazzi L; Maggioni AP
    Ital Heart J; 2002 Nov; 3(11):656-64. PubMed ID: 12506524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
    Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
    Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome.
    Oliva F; Mortara A; Cacciatore G; Chinaglia A; Di Lenarda A; Gorini M; Metra M; Senni M; Maggioni AP; Tavazzi L;
    Eur J Heart Fail; 2012 Nov; 14(11):1208-17. PubMed ID: 22833614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of comorbidity on medication use in elderly patients with cardiovascular diseases: the OCTOCARDIO study.
    Moubarak G; Ernande L; Godin M; Cazeau S; Vicaut E; Hanon O; Zuily S; Tournoux F; Danchin N; Derumeaux G; Mechulan A
    Eur J Prev Cardiol; 2013 Aug; 20(4):524-30. PubMed ID: 22447578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of guideline-consistent heart failure drug prescriptions at hospital discharge on 1-year mortality: Results from the EPICAL2 cohort study.
    Busson A; Thilly N; Laborde-Castérot H; Alla F; Messikh Z; Clerc-Urmes I; Mebazaa A; Soudant M; Agrinier N
    Eur J Intern Med; 2018 May; 51():53-60. PubMed ID: 29305071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction.
    Kerzner R; Gage BF; Freedland KE; Rich MW
    Am Heart J; 2003 Aug; 146(2):286-90. PubMed ID: 12891197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
    Hillege HL; Nitsch D; Pfeffer MA; Swedberg K; McMurray JJ; Yusuf S; Granger CB; Michelson EL; Ostergren J; Cornel JH; de Zeeuw D; Pocock S; van Veldhuisen DJ;
    Circulation; 2006 Feb; 113(5):671-8. PubMed ID: 16461840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure.
    Bagchi AD; Esposito D; Kim M; Verdier J; Bencio D
    Clin Ther; 2007 Aug; 29(8):1771-83. PubMed ID: 17919558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns for heart failure in a primary care environment.
    Simko RJ; Stanek EJ
    Am J Manag Care; 1997 Nov; 3(11):1669-76. PubMed ID: 10178465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study.
    Störk S; Hense HW; Zentgraf C; Uebelacker I; Jahns R; Ertl G; Angermann CE
    Eur J Heart Fail; 2008 Dec; 10(12):1236-45. PubMed ID: 18996739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALERT-HF: adherence to guidelines in the treatment of patients with chronic heart failure.
    Franco G; Biagio F; Battista ZG; De Simone A; Stabile G; Bossone E; Volpe E; Bosso G; Saccà L; Oliviero U;
    J Cardiovasc Med (Hagerstown); 2014 Jun; 15(6):491-7. PubMed ID: 24983269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.
    Yusuf S; Pfeffer MA; Swedberg K; Granger CB; Held P; McMurray JJ; Michelson EL; Olofsson B; Ostergren J;
    Lancet; 2003 Sep; 362(9386):777-81. PubMed ID: 13678871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of a patient education programme in heart failure with preserved ejection fraction: Results from the ODIN cohort study using propensity score matching.
    Agrinier N; Schockmel M; Thilly N; Laborde-Castérot H; Jourdain P; Alla F; Leclercq C; Dany F; Druelle J; Drouet E; Mulak G; Juillière Y;
    Arch Cardiovasc Dis; 2018 Jan; 111(1):5-16. PubMed ID: 28943262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term trends in drug prescription for hospitalized patients with congestive heart failure. Influence of type of dysfunction].
    Grigorian Shamagian L; Varela Román A; Virgos Lamela A; Rigueiro Veloso P; García Acuña JM; González-Juanatey JR
    Rev Esp Cardiol; 2005 Apr; 58(4):381-8. PubMed ID: 15847735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.